Skip to main content

Table 2 Comparison of IPNB patients with dysplasia and invasive carcinoma

From: Clinicopathologic characteristics and long-term prognosis of intraductal papillary neoplasm of the bile duct: a retrospective study

 

Dysplasia (n = 20)

Invasive carcinoma (n = 23)

P

Male/female (n)

10/10

11/12

0.887

Age (years)

60 (50.5–72)

64 (55–68.5)

0.609

BMI (kg/m2)

23.9 ± 3.3

24.7 ± 3.7

0.438

Symptoms (n)

 Abdominal pain

8

10

0.818

 Jaundice

10

16

0.191

 Fever

7

10

0.571

Imaging features (n)

 Choledocholithiasis

3

3

1.000

 Hepatolithiasis

3

2

0.650

 Biliary dilatation

18

22

0.590

 Intraluminal mass

11

9

0.298

 Biliary stricture

6

3

0.263

 Biliary wall thickening

5

4

0.711

Abnormal liver function (n)

8

16

0.052

Abnormal bilirubin (n)

9

10

0.920

CEA > 5 µg/L (n)

3

7

0.405

CA19-9 > 34 U/mL (n)

11

15

0.494

Operation time (min)

219.7 ± 77.5

305.7 ± 91.2

0.004

Patients without surgery (n)

4

1

0.167

Intrahepatic/extrahepatic (n)

10/10

11/12

0.887

Positive margin (n)

1

4

0.351

Survival (n)

10

7

0.191

Survival without tumor (n)

10

5

0.052

  1. IPNB intraductal papillary neoplasm of the bile duct, BMI body mass index, CEA carcino-embryonic antigen, CA19-9 carbohydrate antigen 19–9